2025-03-04 - Analysis Report
## UnitedHealth Group Inc. (UNH) Stock Report

**0. Summary Statistics:**

UNH, UnitedHealth Group Inc., is a diversified healthcare company.  The provided data shows a cumulative return significantly outperforming the S&P 500 (VOO) over the analyzed period.  However, recent price action suggests a potential short-term slowdown, indicated by moving averages and RSI.  Earnings show some volatility, but overall revenue remains strong.

**1. Performance Comparison:**

* **UNH Cumulative Return:** 118.01%
* **VOO (S&P 500) Cumulative Return:** 116.17%
* **Return Difference:** 1.84% (UNH outperformed VOO)
* **Relative Divergence:** 5.1% (This means UNH's performance relative to VOO is in the 95th percentile based on historical data)

The provided historical CAGR, MDD (Maximum Drawdown), Alpha, and Beta show consistent outperformance against the market (positive alpha) with relatively moderate beta (systematic risk).  Note that the last two years show negative CAGR; this warrants further investigation, which is done in the analysis below.  The market capitalization (Cap(B)) shows steady growth over the years.


**2. Recent Price Movement:**

* **Closing Price:** $474.96
* **Last Market Price:** $469.82 (a decrease of -$1.08 from previous close)
* **5-Day Moving Average:** $467.80
* **20-Day Moving Average:** $510.10
* **60-Day Moving Average:** $522.93

The stock price is currently below all three moving averages, indicating a possible bearish trend in the short term. The recent price drop is reflected in the provided "Last-market" data.

**3. Technical Indicators & Expected Return:**

* **RSI:** 30.64 (Suggests the stock is in oversold territory, potentially indicating a bounce back, but caution is needed)
* **PPO:** -1.07 (Negative PPO suggests bearish momentum)
* **Recent Relative Divergence:** +5.1 (Indicates a recent short-term upward movement relative to the S&P 500)
* **Expected Return (2+ years):** 1534.8% (This exceptionally high figure needs further justification and context.  It likely represents a projection based on a specific model that is not detailed here. It is crucial to understand the assumptions and limitations of this projection).
* **Price Change Note:** The recent price change of -$1.08 (a relatively small percentage drop), while showing a short-term downward movement doesn't suggest a drastic "crash" or "sharp drop".

**4. Recent Earnings Analysis:**

| Date       | EPS    | Revenue       |
|------------|--------|---------------|
| 2024-11-04 | $6.56  | $100.82B      |
| 2024-08-09 | $4.58  | $98.86B       |
| 2024-05-09 | -$1.53 | $99.80B       |
| 2023-11-06 | $6.31  | $92.36B       |
| 2024-11-04 | $6.31  | $92.36B       |


There seems to be a data duplication in the table.  Noteworthy is the negative EPS in Q2 2024, which requires further analysis to understand the underlying reasons.  Overall revenue remains consistently high.

**5. Financial Information:**

**Revenue and Profitability:**

| Quarter     | Revenue      | Profit Margin |
|-------------|--------------|---------------|
| 2024-12-31  | $100.81B     | 21.14%        |
| 2024-09-30  | $100.82B     | 22.84%        |
| 2024-06-30  | $98.86B      | 22.31%        |
| 2024-03-31  | $99.80B      | 23.05%        |
| 2023-12-31  | $94.43B      | 23.30%        |

Profit margins are generally healthy and relatively consistent, though they show slight fluctuations. Revenue shows strong and consistent numbers.


**Capital and Profitability:**

| Quarter     | Equity       | ROE           |
|-------------|--------------|---------------|
| 2024-12-31  | $92.66B      | 5.98%         |
| 2024-09-30  | $94.53B      | 6.41%         |
| 2024-06-30  | $89.36B      | 4.72%         |
| 2024-03-31  | $86.69B      | -1.63%        |
| 2023-12-31  | $88.76B      | 6.15%         |

ROE shows some volatility, with a significant negative value in Q1 2024, mirroring the negative EPS.  This warrants further investigation into the specific factors affecting profitability.


**6. Overall Analysis:**

UNH has historically outperformed the S&P 500, showing strong cumulative returns and positive alpha.  However, recent price action and technical indicators suggest a potential short-term bearish trend.  The negative EPS and ROE in Q1 2024 and the slightly concerning data duplication requires additional investigation to understand the underlying reasons and ensure a more comprehensive assessment.  While the long-term expected return is very high, its validity depends heavily on the underlying assumptions and should be treated with caution.  Further investigation is needed into the reasons for the negative EPS and ROE in Q1 2024 before making any investment decisions.  The high expected return requires more detailed explanation of the methodology used for its calculation.
